Targeting Gastrointestinal Disorders and Related Pain with Dr. Preston Klassen Arena Pharmaceuticals

Published: June 12, 2019, 4:21 p.m.

Preston Klassen, MD Chief Medical Officer, Arena Pharmaceuticals talks about the challenges of treating Inflammatory Bowel Diseases (IBD) and Arena's developmental therapies for ulcerative colitis and Crohn's disease.\xa0 We also talk about the development of a treatment for related gastrointestinal pain with a non-opioid alternative.

#Arena\xa0 #Ulcerativecolitis #GI\xa0 #IBD\xa0 #crohns

@ArenaPharm\xa0

Arena Pharmaceuticals

\xa0

\xa0

Arena Pharmaceuticals